ScreenerHero
OPTHOptimi Health Corp. Common Shares
NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · optimihealth.ca
4.730USD-2.87%Mkt Cap: 27.08M $P/E: —

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$65.19BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.89BUSDP/E 12.7
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.4
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
SFZN
Siegfried Holding AG
$4.01BUSDP/E 20.9
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
HIK
Hikma Pharmaceuticals PLC
$3.69BUSDP/E 12.7
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.32BUSDP/E 16.5
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD
HeadlineSourceTime
Today
3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now

Psychedelics stocks are becoming more popular as more research goes into them. Here are 3 stock ideas for your watchlist.

Simply Wall St.
This week
Optimi Health Establishes $100 Million Equity Facility as Psychedelic Commercialisation Advances

Optimi Health has added financial flexibility to its growth strategy as it advances its MDMA and psilocybin business.

Simply Wall St.
Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Key Takeaways; Cannabis Sector Curaleaf Holdings Announced Intention to Launch a Hostile Takeover Bid to Acquire Aurora Cannabis Organigram Posted Record Quarter as Sanity Group Acquisition Fueled Global Expansion Key Takeaways; Psychedelic Sector Optimi Health Set Up US$100 Million Equity Facility to Support Growth Definium Therapeutics’ Phase 3 Trial Delivered Strong Results for DT120 in […]

MMarket Exclusive
Older
3 Psychedelic Stocks With Potential Clinical Trial Catalysts

Big pharma is funding a field it once dismissed. These three psychedelic stocks carry possible clinical catalysts as the healthcare industry turns to alternative medicines.

Simply Wall St.
Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel

Optimi Health advances ibogaine strategy amid rising regulatory and research support.

Simply Wall St.
Optimi Health up 2.5% as It Completes Commercial 5mg Psilocybin Production Run

Optimi Health (OPTI.CN), up 2.5% on last look, on Tuesday said it completed a production run of its

MMT Newswires
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision

SRx Health, which is merging with EMJ Crypto Technologies, said EMJ’s proprietary operating system used quantitative models and artificial intelligence to pick Optimi Health as an investment opportunity.

Stocktwits